Starting from the spring of 2018, Viagra tablets will be sold over the counter in UK pharmacies without a prescription. Now drugs for erectile dysfunction can only be bought after a doctor’s recommendation.
In spring, any man over the age of 18 will be able to freely purchase pills after a short conversation with a pharmacist. A pack of four will cost about £ 20, and a pack of eight tablets will cost about £ 35.
The decision to revise the classification of Viagra and remove it from the list of drugs that are sold strictly according to a prescription was made following a public discussion and on the advice of the Commission on Human Medicines. Experts decided that after this, men who avoid doctors will stop buying illegal prescriptions for the “blue pill” on the Internet. It is also expected that this will help reduce the criminal turnover of Viagra and its analogues, which over the past five years amounted to £ 50 million.
According to the new classification, in the spring the drug will go on public sale under the name Viagra Connect and will contain the same active substance – sildenafil. Representatives of the company Pfizer (which produces Viagra) are already conducting joint trainings with pharmacies. Each will have a special room where any man who wishes can talk to a pharmacist and ask him questions before buying a drug. Specialists in pharmacies will inform buyers about side effects, and those, in turn, should be aware of their chronic diseases. Men who still have problems with their heart, kidneys, and liver should always consult a doctor before using Viagra.
We understand that many men avoid counseling and treating various manifestations of erectile dysfunction, so we believe that a short consultation with a pharmacist before buying Viagra Connect will be the first step in recognizing your problem and, perhaps, the desire to see a doctor. We also hope that the ability to freely get medicine for potency will reduce the number of men who buy ineffective and even dangerous fakes said Dr. Berkeley Phillips, medical director of the British unit Pfizer.